The purpose of this study is to investigate pancreatic ductal adenocarcinoma. It will explore the safety of combining oral fecal microbiota transplantation with chemotherapy in patients with this condition.
This study evaluates how safe the combination treatment is and looks at different outcomes for patients. It focuses on analyzing the gut microbiome and the immune system's response.
- Who can participate: Adults aged 18 and older with a confirmed diagnosis of unresectable or metastatic pancreatic ductal adenocarcinoma can participate. Eligible participants should be able to consent to treatment.
- Study details: Participants will take part in a study that combines chemotherapy with oral fecal microbiota transplantation. They will receive treatment with an investigational medication.